In oral squamous cell carcinoma, NRP1 promotes EMT by activating NF-κB pathway; conversely inhibiting NF-κB pathway reverses the NRP1-mediated EMT process [105]. This evidence concerns the gene NFKB1 and oral cavity squamous cell carcinoma.